Stempeutics Research Pvt Ltd
10
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
2 terminated/withdrawn out of 10 trials
75.0%
-11.5% vs industry average
20%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Role: collaborator
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
Role: collaborator
A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease
Role: lead
Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
Role: lead
A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
Role: lead
Allogeneic Mesenchymal Stem Cells in Osteoarthritis
Role: lead
Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke
Role: lead
Allogeneic Mesenchymal Stem Cells for Osteoarthritis
Role: lead
Mesenchymal Stem Cells in Critical Limb Ischemia
Role: lead
Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI
Role: lead
All 10 trials loaded